Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 20, 2026.

Virulence reduction in bacteriophage resistant bacteria

Marcela León, Roberto Bastías

Frontiers in Microbiology · 2015

doi:10.3389/fmicb.2015.00343

Abstract

Bacteriophages can influence the abundance, diversity, and evolution of bacterial communities. Several bacteriophages have been reported to add virulence factors to their host and to increase bacterial virulence. However, lytic bacteriophages can also exert a selective pressure allowing the proliferation of strains with reduced virulence. This reduction can be explained because bacteriophages use structures present on the bacterial surface as receptors, which can be virulence factors in different bacterial species. Therefore, strains with modifications in these receptors will be resistant to bacteriophage infection and may also exhibit reduced virulence. This mini-review summarizes the reports on bacteriophage-resistant strains with reductions in virulence, and it discusses the potential consequences in phage therapy and in the use of bacteriophages to select attenuated strains for vaccines.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 20, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Bacteriophages are likely the most abundant microorganisms on earth. They can affect the evolution of bacteria through lysogenic conversion and transduction, and they can exert selective pressure due to their lytic effects. The role of bacteriophages in increasing bacterial virulence has been widely studied. However, the effect of bacteriophages on the reduction of bacterial virulence is still poorly understood and has not been reviewed.

Although bacteria can have mechanisms to resist phage infection, such as the Restriction Modification System and the CRISPR-Cas system, the proliferation of bacteriophage resistant (BR thereafter) strains is a natural process associated with spontaneous mutations and adaptation, frequently related to modifications in bacteriophage receptors. Virtually any structure on the cell surface can be a receptor, and its recognition by bacteriophage proteins determines bacteriophage specificity and host range. These structures can be classified according to their structural characteristics, and they have several roles, including acting as virulence factors. Modifications in bacteriophage receptors will confer resistance to bacteria; however, this resistance could have a secondary cost for the bacteria. The modifications may result in lower fitness compared to non-resistant strains. According to several reports (Table 1), bacteriophage resistance can also be related to lower virulence, making the resistant bacteria less virulent than the non-resistant ones. This review discusses the association between bacteriophage resistance and virulence reduction in bacteria due to modifications in bacteriophage receptors, and it discusses the potential implications of this phenomenon.

Bacteriophage Receptors in Gram-Negative Bacteria

The Gram-negative cell wall comprises several layers, with an outer membrane that differs from the membranes present in Gram-positive bacteria. The external layer of the outer membrane is composed of lipopolysaccharide (LPS), which is present only in Gram-negative bacteria and is associated with endotoxicity. There are several proteins, called outer membrane proteins (OMPs), that are embedded in the membrane and participate primarily in transport and diffusion mechanisms. Both LPS and OMPs have been related to virulence in various Gram-negative bacteria, and they are also bacteriophage receptors, which in some cases are necessary simultaneously for adsorption.

Lipopolysaccharide

Lipopolysaccharide is composed of lipid A and polysaccharides. This molecule is a potent endotoxin, and its role in virulence has been widely discussed. Variations in the lipid A of three pathogenic bacteria from the genus Yersinia produce alterations in virulence; Likewise, the genes wbaP, wzy, and wzz participate in O-antigen synthesis and are necessary for human serum resistance to Salmonella enterica serovar Typhi. LPS is also a receptor for numerous bacteriophages. Direct interaction between phage proteins and LPS has been demonstrated, including by X-ray crystallography evidence.

showed that the loss of LPS in Salmonella produces changes in bacteriophage susceptibility and the loss of virulence in mice. More recent work has shown that strains of Salmonella enterica serovar Enteritidis resistant to the lytic phages f2αSE, f3αSE, and f18αSE are avirulent in the nematode Caenorhabditis elegans. The BR strains show abnormal colony morphology and lack the O-polysaccharide from LPS, suggesting that modifications in this structure may be involved in resistance and the loss of virulence. A similar situation was observed with the strain Salp572ϕ1S of Salmonella enterica serovar Paratyphi B and bacteriophage ϕ1. A BR strain called Salp572ϕ1R lacks the O-polysaccharide from LPS, and gene expression analysis has revealed that Salp572ϕ1R under-expresses several genes related to virulence, such as cmE, sthE, and cheY (periplasmic heme-dependent peroxidase, a putative major fimbrial subunit, and a chemotaxis regulator, respectively). Moreover, Salp572ϕ1R was completely avirulent in mice; whereas the parental sensitive strain Salp572ϕ1S killed the mice after 48 h of infection. These examples strongly suggest that modifications in LPS can produce bacteriophage resistance and decrease virulence simultaneously.

Outer Membrane Proteins

Outer membrane proteins have several functions in the cell. These proteins have also been related to virulence in Listonella anguillarum, Helicobacter pylori, Escherichia coli, Neisseria meningitidis, Salmonella Typhimurium, and several Vibrio species. In L. anguillarum, five OMPs are related to osmolarity regulation, which occurs when the bacteria move from seawater to lower salinity environments in the host. In E. coli, the proteins OmpW and OmpA participate in immune system evasion.

Outer membrane proteins are recognized receptors for numerous bacteriophages, including the bacteriophage Lambda, whose receptor is the protein LamB from E. coli. BR strains with mutations in OMPs have repeatedly been found. For example, BR strains from E. coli K-1 present alterations in the protein sequence of OmpA, which participates in conjugation, adhesion, and immune system evasion, and is a receptor for several T-even-like bacteriophages. Although there are no studies on virulence reduction in these strains, it is possible that mutations in OmpA also alter bacterial adhesion or immune system evasion.

Bacteriophage Receptors in Gram-Positive Bacteria

The Gram-positive cell wall lacks the LPS present in Gram-negative membranes, but it has a thick layer of peptidoglycan interspersed with acid polysaccharides called teichoic acids. In addition to their structural function, these molecules can contribute to virulence by participating in adhesion and toxicity. These structures are also receptors for several bacteriophages. For example, the infection of Listeria monocytogenes by bacteriophages A118 and A500 depends on cell wall teichoic acids, and the broad host range of Listeria bacteriophage A511 recognizes only the peptidoglycan. Similarly, the bacteriophage SPP1 from Bacillus subtilis binds to teichoic acids in a reversible manner, and the presence of these polysaccharides accelerates adsorption.

Teichoic acids are important for the virulence of Staphylococcus aureus because strains lacking this polysaccharide exhibit a reduction in the adherence to human endothelial cells and attenuated virulence in rabbits. Likewise, the lack of D-alanine in teichoic acids increases susceptibility to human neutrophils and decreases virulence against mice. Recent studies performed with the bacteriophage Msa of S. aureus showed that a resistant strain called 172 under-expresses several genes related to virulence, such as sbi (IgG-binding protein), ica (N-glycosyltransferase), and a gene for an α-hemolysin. This strain also has a reduced growth rate, and unlike the parental strain, it produces a capsular polysaccharide. The N-acetylglucosamine from teichoic acids was identified as a bacteriophage receptor because phage infection was inhibited in the presence of these polysaccharides and because strain 172 lacks N-acetylglucosamine. Intramuscular injection with 172 was not lethal, and it was an effective vaccine against infection with other S. aureus strains. These findings suggest that the missing N-acetylglucosamine in 172, in addition to its role as a bacteriophage receptor, may also be involved in virulence. However, it is also possible that capsular polysaccharide production confers resistance to bacteriophage infection, as occurs in other bacterial species.

Capsule

The capsule (K antigen) is an external structure composed of polysaccharides found surrounding the cells of several bacterial species, and it has been related to adhesion and evasion of the immune system. Bacteria with a capsule, such as Streptococcus pneumonia, are more resistant to phagocytosis, and as a consequence, they are more virulent. Mutants deficient in this structure have a significant reduction in their virulence compared to wild type strains.

Although the capsule is commonly associated with bacteriophage resistance, some bacteriophages can recognize this structure as a receptor, and they have evolved along with the bacteria to recognize different types of K antigen. The podophage K1-5 of E. coli has two types of tail fiber proteins, which allow it to recognize bacteria with K1 and K5 antigens, and it has two specific glycosidases that enable it to penetrate both types of capsules. It has been reported that E. coli strains lacking the K antigen are insensitive to phage infection. Therefore, if the capsule is recognized as a receptor, the proliferation of BR strains can be associated with virulence reduction due to the participation of this structure in the evasion of the immune system. In this case, the potential virulence reduction in BR strains will depend on the role of the capsule in the specific bacterial species because there are examples of BR strains with alterations in capsule receptors but unaltered virulence.

Bacterial Appendices and Other Factors Associated with Motility

The bacterial flagellum allows bacteria to move into favorable environments and escape from unfavorable environments. In the early stages of infection, the flagellum allows a pathogen to reach the host, and participates in the adhesion process. The flagellum has been reported to be an important virulence factor in Pseudomonas aeruginosa, Vibrio cholerae, Salmonella enterica serovar typhimurium, H. pylori and many species. Strains of V. anguillarum with deletions in the N-terminal region of flagellin A, a major component of the flagellum filament, have reduced motility, and they show reduced virulence in rainbow trout (Oncorhynchus mykiss) when the fish is infected through bath treatment, demonstrating the importance of flagella during the first steps of infection. The flagellum was one of the first bacteriophage receptors identified, and it is now a recognized receptor for numerous bacteriophages. According to several reports, the flagellum is used as a primary receptor to increase the local concentration of bacteriophages, and it facilitates interaction with a secondary receptor located on the bacterial surface. However, there are also phages that inject their DNA directly into the flagellum filament. Thus, it is probable that bacteria with mutations in their flagella-encoding genes will have impaired motility and will be more resistant to bacteriophages that use this structure as a receptor.

Indirect associations between motility, virulence, and bacteriophage resistance were observed by when they used temperature and bacteriophages as selective pressures to isolate BR mutant strains from Serratia marcescens with changes in virulence traits. The isolated mutants had increased motility and virulence against the insect Parasemia plantaginis; however, these mutant strains were detected only when the bacteria were grown in the absence of bacteriophages, suggesting an inverse correlation between the presence of bacteriophages and virulence. A clearer link was observed with bacteria from the genus Flavobacterium, which exhibit gliding motility. This mechanism of motility involves proteins from the cell surface and does not involve pili or flagella. showed that BR strains from the fish pathogen Flavobacterium columnare present abnormal rough colony morphology and have reduced motility. Moreover, the resistant strains were totally avirulent in zebrafish (Danio rerio), while the ancestral strains produced a 25–100% mortality rate. As occurs with the flagella, proteins related to gliding motility are important for virulence; therefore, it is likely that mutations conferring resistance to bacteriophages in these strains also impair bacterial motility and reduce virulence. A similar situation was observed in BR strains of B. thuringiensis: a subset of the resistant strains lack flagella and have reduced virulence in the pupae of the cecropia moth (Hyalophora cecropia); however, no direct relationship between bacteriophage resistance and virulence was observed because fully virulent BR strains were also isolated.

The pilus is another filamentous appendage that is present in some bacteria, but it is smaller than the flagellum. This structure has been related to virulence and many other functions in bacteria, and it acts as a receptor for many bacteriophages. The most well described case is the bacteriophage ΦCTX of V. cholearae, which carries a gene coding for the cholera toxin (CT) and infects bacteria using a toxin co-regulated pilus (TCP). This pilus is also considered a virulence factor in the bacterium, and both the CT and the TCP are necessary for a fully virulent bacterium. Therefore, in V. cholerae strains lacking the TCP receptor or with modifications, the receptor cannot be infected by the ΦCTX phage, and these strains are less likely to increase their virulence.

Discussion

The main mechanism driving bacteria and bacteriophage co-evolution is spontaneous mutation. The random nature of mutations can lead to different phenotypes, including reduced virulence in BR strains. Therefore, the mutation will determine the effect on the bacterium, and it will likely determine the level of virulence reduction. Mutations in regulators of gene expression are generally more likely to result in resistance and virulence reduction because more genes are affected by them. This mechanism may have occurred for strain Salp572ϕ1R of Salmonella enterica and strain 172 of S. aureus because several genes were found to be under-expressed in both cases. Whether the BR strain with reduced virulence will persist will depend on several factors, such as the presence of bacteriophage, the availability of nutrients and the environmental conditions. Without the selective pressure of bacteriophages, the BR strains can revert to the parental phenotype, as was observed by with B. thuringiensis, or the BR stains may be displaced by non-resistant strains with better fitness. observed that strain Salp572ϕ1R can persist for only a short period of time in vivo, likely due to the impairment of virulence factors. However, the same bacterium would have better chances of persisting outside of the host in an environment with predators. Interestingly, a BR strain can become resistant to several bacteriophages simultaneously, as was observed by and others. This multi-resistance likely occurs because the bacteriophages tested use the same receptor. However, in other cases, the acquisition of resistance against particular bacteriophages can increase susceptibility to other bacteriophages, demonstrating the complexity of this phenomenon in the environment.

Some of the articles mentioned here describe the use of bacteriophages as antimicrobial agents, for which the proliferation of resistant bacteria is a major drawback. The results showed that despite BR strain proliferation, the bacteriophage treatments were successful in protecting against bacterial infection; this result was likely due to the virulence reduction in BR strains. Moreover, there are several alternatives to overcome this problem, such as the use of phage cocktails. These examples support the use of phages to control pathogenic bacteria; however, this is not a general situation for all phage-bacteria systems because BR strains with unaltered virulence have been isolated previously. Additionally, BR strains of P. aeruginosa PAO1 were found to produce higher levels of secreted virulence factors than the parental strain, and bacteriophages can induce a mucoid phenotype in P. fluorescens, which is normally associated with virulence in other Pseudomonas sp.. Hence, potential alterations in the virulence of BR strains should be determined for every phage-bacteria system, especially if bacteriophages are to be considered for an antimicrobial treatment.

suggested that bacteriophages could be useful for developing new vaccines due to their ability to select attenuated resistant strains. They showed that BR strain 172 of S. aureus was an effective vaccine in mice against lethal doses of different S. aureus strains, including methicillin-resistant S. aureus (MRSA). The vaccine was effective even when the bacteria were heat-killed, whereas the heat-killed parental strain 170 was not effective. The resistant strain presents a lower growth rate, exhibits under-expression of several virulence genes, and produces extracellular polysaccharide, which, although it is missing in wt strains, also has a protective effect in a vaccine. Moreover, this strain modulates the transcription of pro-inflammatory genes (TNF-α, IFN-γ, and IL-1β), and it induces the expression of anti-inflammatory genes (Il-4 and Il-6) in mice. The authors suggest that the use of bacteriophages can facilitate vaccine preparation, allowing the selection of attenuated BR strains. The same authors performed similar work with Salmonella enterica serovar Paratyphi B. In that case, the BR strains were avirulent and proved to be excellent vaccines in mice, supporting the potential use of phages in vaccine development. However, their use should be evaluated carefully in each case by considering the potential of a temperate bacteriophage to increase bacterial virulence.

Conclusion

Bacteriophages can influence the proliferation of new virulent strains. However, although there have been a few reports, the role of bacteriophages in selecting less virulent strains has not been studied in detail. The information presented here suggests that potential changes in the virulence of BR strains depend on the specific bacteriophage-host system. Therefore, this phenomenon must be explored comprehensively, especially if bacteriophages are to be used in phage therapy or in vaccine development. The cases presented here summarize the information regarding this phenomenon and should be thought of as an incentive to analyze the potential changes in virulence of resistant bacteria every time a phage-bacterial system is investigated.

References 78

  1. 1.

    Attridge S. R. Fazeli A. Manning P. A. Stroeher U. H. (2001 ). Isolation and characterization of bacteriophage-resistant mutants of Vibrio cholerae O139. Microb. Pathog. 30 237–246

    Not in our library10.1006/mpat.1006.2000.0426

  2. 2.

    Baptista C. Santos M. A. Sao-Jose C. (2008 ). Phage SPP1 reversible adsorption to Bacillus subtilis cell wall teichoic acids accelerates virus recognition of membrane receptor YueB. J. Bacteriol. 190 4989–4996

    Not in our library10.1128/jb.00349

  3. 3.

    Betts A. Kaltz O. Hochberg M. E. (2014 ). Contrasted coevolutionary dynamics between a bacterial pathogen and its bacteriophages. Proc. Natl. Acad. Sci. U.S.A. 111 11109–11114

    Not in our library10.1073/pnas.1406763111

  4. 4.

    Boneca I. G. (2005 ). The role of peptidoglycan in pathogenesis. Curr. Opin. Microbiol. 8 46–53

    Not in our library10.1016/j.mib.2004.12.008

  5. 5.

    Brown S. Maria J. P. S. Walker S. (2013 ). “Wall teichoic acids of gram-positive bacteria,” in Annual Review of Microbiology, Vol. 67 ed. Gottesman S. (Palo Alto: Annual Reviews), 313–336.

    Not in our library10.1146/annurev-micro-092412-155620

  6. 6.

    Brussow H. Canchaya C. Hardt W. D. (2004 ). Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol. Mol. Biol. Rev. 68 560–602

    Not in our library10.1128/mmbr.68.3.560-602.2004

  7. 7.

    Bugla-Ploskonska G. Futoma-Koloch B. Doroszkiewicz W. (2007 ). Role of outer membrane proteins of Gram-negative bacteria in interaction with human organism. Postepy Mikrobiol. 46 139–152.

    Not in our library

  8. 8.

    Canchaya C. Fournous G. Chibani-Chennoufi S. Dillmann M. L. Brussow H. (2003 ). Phage as agents of lateral gene transfer. Curr. Opin. Microbiol. 6 417–424

    Not in our library10.1016/s1369-5274(03)00086-9

  9. 9.

    Capparelli R. Nocerino N. Iannaccone M. Ercolini D. Parlato M. Chiara M. (2010a ). Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J. Infect. Dis. 201 52–61

    Not in our library10.1086/648478

  10. 10.

    Capparelli R. Nocerino N. Lanzetta R. Silipo A. Amoresano A. Giangrande C. (2010b ). Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice. PLoS ONE 5:e11720

    Not in our library10.1371/journal.pone.0011720

  11. 11.

    Chart H. Row B. Threlfall E. J. Ward L. R. (1989 ). Conversion of Salmonella enteritidis phage type 4 to phage type 7 involves loss of lipopolysaccharide with concomitant loss of virulence. FEMS Microbiol. Lett. 51 37–40

    Not in our library10.1111/j.1574-6968.1989.tb03415.x

  12. 12.
  13. 13.

    Choi Y. Shin H. Lee J. H. Ryu S. (2013 ). Identification and characterization of a novel flagellum-dependent Salmonella-infecting bacteriophage, iEPS5. Appl. Environ. Microbiol. 79 4829–4837

    Not in our library10.1128/aem.00706-13

  14. 14.

    Collins L. V. Kristian S. A. Weidenmaier C. Faigle M. Van Kessel K. P. M. Van Strijp J. A. G. (2002 ). Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J. Infect. Dis. 186 214–219

    Not in our library10.1086/341454

  15. 15.

    Eaton K. A. Morgan D. R. Krakowka S. (1992 ). Motility as a factor in the colonization of gnotobiotic piglets by Helicobacter pylori. J. Med. Microbiol. 37 123–127

    Not in our library10.1099/00222615-37-2-123

  16. 16.

    Feldman M. Bryan R. Rajan S. Scheffler L. Brunnert S. Tang H. (1998 ). Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 66 43–51.

    Not in our library10.1128/iai.66.1.43-51.1998

  17. 17.

    Friman V. P. Hiltunen T. Jalasvuori M. Lindstedt C. Laanto E. Ormala A. M. (2011 ). High temperature and bacteriophages can indirectly select for bacterial pathogenicity in environmental reservoirs. PLoS ONE 6:e17651

    Not in our library10.1371/journal.pone.0017651

  18. 18.

    Fuhrman J. A. (1999 ). Marine viruses and their biogeochemical and ecological effects. Nature 399 541–548

    Not in our library10.1038/21119

  19. 19.
  20. 20.

    Heierson A. Sidén I. Kivaisi A. Boman H. G. (1986 ). Bacteriophage-resistant mutants of Bacillus thuringiensis with decreased virulence in pupae of Hyalophora cecropia. J. Bacteriol. 167 18–24.

    Not in our library10.1128/jb.167.1.18-24.1986

  21. 21.

    Hoare A. Bittner M. Carter J. Alvarez S. Zaldivar M. Bravo D. (2006 ). The outer core lipopolysaccharide of Salmonella enterica Serovar typhi is required for bacterial entry into epithelial cells. Infect. Immun. 74 1555–1564

    Not in our library10.1128/iai.74.3.1555-1564.2006

  22. 22.

    Hosseinidoust Z. Van De Ven T. G. M. Tufenkji N. (2013 ). Evolution of Pseudomonas aeruginosa virulence as a result of phage predation. Appl. Environ. Microbiol. 79 6110–6116

    Not in our library10.1128/aem.01421-13

  23. 23.

    Hyman P. Abedon S. T. (2010 ). “Bacteriophage host range and bacterial resistance,” in Advances in Applied Microbiology, Vol. 70 eds Laskin A. I. Sariaslani S. Gadd G. M. (San Diego: Elsevier Academic Press Inc), 217–248.

    Not in our library10.1016/s0065-2164(10)70007-1

  24. 24.

    Inagaki M. Tanaka A. Suzuki R. Wakashima H. Kawaura T. Karita S. (2000 ). Characterization of the binding of spike H protein of bacteriophage phi X74 with receptor lipopolysaccharides. J. Biochem. 127 577–583

    Not in our library10.1093/oxfordjournals.jbchem.a022643

  25. 25.

    Inoue T. Matsuzaki S. Tanaka S. (1995 ). A 26-kDa outer membrane protein, OmpK, common to Vibrio species is the receptor for a broad-host-range vibriophage, KVP40. FEMS Microbiol. Lett. 125 101–105.

    Not in our library10.1111/j.1574-6968.1995.tb07342.x

  26. 26.

    Ishiguro E. E. Ainsworth T. Shaw D. H. Kay W. W. Trust T. J. (1983 ). A lipopolysaccharide-specific bacteriophage for Aeromonas salmonicida. Can. J. Microbiol. 29 1458–1461

    Not in our library10.1139/m83-223

  27. 27.

    Josenhans C. Suerbaum S. (2002 ). The role of motility as a virulence factor in bacteria. Int. J. Med. Microbiol. 291 605–614

    Not in our library10.1078/1438-4221

  28. 28.

    Kao D. Y. Cheng Y. C. Kuo T. Y. Lin S. B. Lin C. C. Chow L. P. (2009 ). Salt-responsive outer membrane proteins of Vibrio anguillarum serotype O1 as revealed by comparative proteome analysis. J. Appl. Microbiol. 106 2079–2085

    Not in our library10.1111/j.1365-2672.2009.04178.x

  29. 29.

    Kiljunen S. Datta N. Dentovskaya S. V. Anisimov A. P. Knirel Y. A. Bengoechea J. A. (2011 ). Identification of the lipopolysaccharide core of Yersinia pestis and Yersinia pseudotuberculosis as the receptor for bacteriophage phi A1122. J. Bacteriol. 193 4963–4972

    Not in our library10.1128/jb.00339-11

  30. 30.

    Koebnik R. Locher K. P. Van Gelder P. (2000 ). Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol. Microbiol. 37 239–253

    Not in our library10.1046/j.1365-2958.2000.01983.x

  31. 31.
  32. 32.
  33. 33.

    Labrie S. J. Samson J. E. Moineau S. (2010 ). Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 8 317–327

    Not in our library10.1038/nrmicro2315

  34. 34.

    Leiman P. G. Battisti A. J. Bowman V. D. Stummeyer K. Muhlenhoff M. Gerardy-Schahn R. (2007 ). The structures of bacteriophages K1E and k1-5 explain processive degradation of polysaccharide capsules and evolution of new host specificities. J. Mol. Biol. 371 836–849

    Not in our library10.1016/j.jmb.2007.05.083

  35. 35.

    Loc-Carrillo C. Abedon S. T. (2011 ). Pros and cons of phage therapy. Bacteriophage 1 111–114

    Not in our library10.4161/bact.1.2.145902159-7073-1-26

  36. 36.

    Marston M. F. Pierciey F. J. Shepard A. Gearin G. Qi J. Yandava C. (2012 ). Rapid diversification of coevolving marine Synechococcus and a virus. Proc. Natl. Acad. Sci. U.S.A. 109 4544–4549

    Not in our library10.1073/pnas.1120310109

  37. 37.

    Mattick J. S. (2002 ). Type IV pili and twitching motility. Annu. Rev. Microbiol. 56 289–314

    Not in our library10.1146/annurev.micro.56.012302.160938

  38. 38.

    McBride M. J. (2004 ). Cytophaga-flavobacterium gliding motility. J. Mol. Microbiol. Biotechnol. 7 63–71

    Not in our library10.1159/000077870

  39. 39.

    Melville S. Craig L. (2013 ). Type IV pili in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 77 323–341

    Not in our library10.1128/mmbr.00063-12

  40. 40.

    Meynell E. W. (1961 ). A phage, φχ, which attacks motile bacteria. J. Gen. Microbiol. 25 253–290

    Not in our library10.1099/00221287-25-2-253

All 78 references

Cited by papers we hold 5

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.